Magnesium in PDB 9hdo: The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex

All present enzymatic activity of The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex:
2.7.7.49;

The structure of The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex also contains other interesting chemical elements:

Zinc

(Zn)

1 atom

The binding sites of Magnesium atom in the The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex (pdb code 9hdo). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex, PDB code: 9hdo:

Magnesium binding site 1 out of 1 in the The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of The Human Line-1 ORF2P Target-Primed Reverse Transcription Complex within 5.0Å range: probe atom residue distance (Å) B Occ A:Mg1301 b:56.6 occ:1.00 O A:ALA601 2.1 60.2 1.0 O2A A:D3T1303 2.1 57.7 1.0 OD2 A:ASP600 2.1 73.5 1.0 O1G A:D3T1303 2.2 63.9 1.0 O2B A:D3T1303 2.2 60.0 1.0 OD2 A:ASP702 2.2 54.7 1.0 CG A:ASP600 3.2 79.6 1.0 C A:ALA601 3.3 63.9 1.0 CG A:ASP702 3.4 51.6 1.0 PB A:D3T1303 3.4 54.7 1.0 PA A:D3T1303 3.4 56.6 1.0 PG A:D3T1303 3.6 64.0 1.0 OD1 A:ASP600 3.7 85.5 1.0 O3A A:D3T1303 3.7 60.8 1.0 O3B A:D3T1303 3.9 56.4 1.0 OD1 A:ASP702 4.0 56.8 1.0 CA A:ALA601 4.1 62.9 1.0 N A:ALA601 4.1 60.6 1.0 CB A:ALA604 4.2 58.1 1.0 C5' A:D3T1303 4.2 58.1 1.0 N A:ALA604 4.3 58.8 1.0 N A:GLU602 4.3 64.0 1.0 CB A:ALA601 4.3 64.5 1.0 O5' A:D3T1303 4.4 55.6 1.0 O3G A:D3T1303 4.4 69.0 1.0 N A:LYS603 4.4 59.7 1.0 CB A:ASP600 4.5 74.5 1.0 O1A A:D3T1303 4.5 68.0 1.0 CA A:GLU602 4.5 65.8 1.0 CB A:ASP702 4.6 46.1 1.0 C A:GLU602 4.7 61.8 1.0 O1B A:D3T1303 4.7 56.4 1.0 C A:ASP600 4.7 63.9 1.0 O2G A:D3T1303 4.7 67.7 1.0 CA A:ALA604 4.9 56.3 1.0

G.E.Ghanim, H.Hu, T.H.D.Nguyen. Structural Mechanism of LINE1 Target-Primed Reverse Transcription To Be Published.